Cargando…

The role of antirheumatics in patients with COVID-19

The COVID-19 pandemic has resulted in more than 2 million deaths globally. Two interconnected stages of disease are generally recognised; an initial viral stage and a subsequent immune response phase with the clinical characteristics of hyperinflammation associated with acute respiratory distress sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nissen, Christoffer B, Sciascia, Savino, de Andrade, Danieli, Atsumi, Tatsuya, Bruce, Ian N, Cron, Randy Q, Hendricks, Oliver, Roccatello, Dario, Stach, Ksenija, Trunfio, Mattia, Vinet, Évelyne, Schreiber, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009617/ https://www.ncbi.nlm.nih.gov/pubmed/33817665 http://dx.doi.org/10.1016/S2665-9913(21)00062-X

Ejemplares similares

Women with gout and COVID-19—an unfortunate combination?
por: Nissen, Christoffer B, et al.
Publicado: (2022)

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It “Idiopathic”?
por: Radin, Massimo, et al.
Publicado: (2018)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians
por: Schreiber, Karen, et al.
Publicado: (2020)

Recent advances in the management of systemic lupus erythematosus
por: Sciascia, Savino, et al.
Publicado: (2018)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
por: Sciascia, Savino, et al.
Publicado: (2016)

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
por: Bazzan, Mario, et al.
Publicado: (2020)

Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab
por: Fenoglio, Roberta, et al.
Publicado: (2022)

Air Pollution from Global Health to Individual Risk Factor—Is It Time for Enviropathies in Everyday Clinical Practice?
por: Sciascia, Savino, et al.
Publicado: (2022)

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents
por: Roccatello, Dario, et al.
Publicado: (2017)

Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience
por: Roccatello, Dario, et al.
Publicado: (2020)

Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease
por: Arbrile, Marta, et al.
Publicado: (2021)

The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy
por: Roccatello, Dario, et al.
Publicado: (2023)

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
por: Sciascia, Savino, et al.
Publicado: (2019)

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation
por: Radin, Massimo, et al.
Publicado: (2021)

Serum Biomarkers of Renal Fibrosis: A Systematic Review
por: Barinotti, Alice, et al.
Publicado: (2022)

The need for kidney biopsy in the management of side effects of target and immunotherapy
por: Fenoglio, Roberta, et al.
Publicado: (2023)

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort
por: Roccatello, Dario, et al.
Publicado: (2017)

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
por: Fenoglio, Roberta, et al.
Publicado: (2018)

Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients
por: Sciascia, Savino, et al.
Publicado: (2022)

Renal involvement as a unique manifestation of hemophagocytic syndrome
por: Roccatello, Dario, et al.
Publicado: (2022)

Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy
por: Roccatello, Dario, et al.
Publicado: (2022)

Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing
por: Barinotti, Alice, et al.
Publicado: (2020)

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
por: Radin, Massimo, et al.
Publicado: (2021)

The “4 plus 2” rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
por: Roccatello, Dario, et al.
Publicado: (2017)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response
por: Rossi, Daniela, et al.
Publicado: (2021)

Recognizing the new disorder “idiopathic hypocryoglobulinaemia” in patients with previously unidentified clinical conditions
por: Roccatello, Dario, et al.
Publicado: (2022)

Coronavirus is the trigger, but the immune response is deadly
por: Cron, Randy Q
Publicado: (2020)

COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)

No perfect therapy for the imperfect COVID-19 cytokine storm
por: Cron, Randy Q
Publicado: (2022)

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
por: Sciascia, Savino, et al.
Publicado: (2021)

A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
por: Roccatello, Dario, et al.
Publicado: (2021)

Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience
por: Sciascia, Savino, et al.
Publicado: (2022)

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
por: Radin, Massimo, et al.
Publicado: (2020)

Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement
por: Quattrocchio, Giacomo, et al.
Publicado: (2020)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing
por: Foddai, Silvia Grazietta, et al.
Publicado: (2023)

New antirheumatic effects of biphosphonate treatment
por: Konenkova, L, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_tn0k3jj01hfau22ovvk31r5ieq